Industry Research Reports
Home > Reports > Medical Devices & Consumables > Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-03-09
Pages: 104 Pages
Report ld: 6067276
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Blood-based Biomarker Market Size(US$)
CAGR 2026-2032
10.4%
Market Size,2032
USD 3,977
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,203 million
Market Forecast in 2032(Value)
US$ 3,977 million
CAGR
10.4%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Blood-based Biomarker was estimated to be worth US$ 2015 million in 2025 and is projected to reach US$ 3977 million, growing at a CAGR of 10.4% from 2026 to 2032.
A blood-based biomarker is a measurable biological molecule found in the blood that indicates normal or pathological processes in the body. These biomarkers can be proteins, nucleic acids, metabolites, or even circulating tumor cells that help diagnose diseases, monitor treatment responses, and predict patient outcomes. Blood-based biomarkers are widely used in oncology, neurology, and cardiovascular diseases, enabling early detection and personalized medicine approaches. Their non-invasive nature makes them highly valuable for routine clinical practice and research.
The North American market for Blood-based Biomarker was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Blood-based Biomarker was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Blood-based Biomarker was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Blood-based Biomarker market include Roche Diagnostics, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abbott, Siemens Healthineers, Danaher, Quidel Corporation, Grifols, Biocartis, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Blood-based Biomarker, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Blood-based Biomarker market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Blood-based Biomarker.
MARKET SEGMENTATION
By Company
- Roche Diagnostics
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Qiagen
- Abbott
- Siemens Healthineers
- Danaher
- Quidel Corporation
- Grifols
- Biocartis
- Vernalis
- Labcorp Drug Development
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Next Generation Sequencing
- Mass Spectrometry
- Liquid Biopsy Technologies
Segment by Application
- Hospital
- Diagnostic Centers
- Research Labs
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.
Chapter 2: Provides a detailed analysis of the Blood-based Biomarker companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Blood-based Biomarker revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Blood-based Biomarker revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.
Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Blood-based Biomarker Product Introduction
1.2 Global Blood-based Biomarker Market Size Forecast (2021–2032)
1.3 Blood-based Biomarker Market Trends & Drivers
1.3.1 Blood-based Biomarker Industry Trends
1.3.2 Blood-based Biomarker Market Drivers & Opportunities
1.3.3 Blood-based Biomarker Market Challenges
1.3.4 Blood-based Biomarker Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blood-based Biomarker Players Revenue Ranking (2025)
2.2 Global Blood-based Biomarker Revenue by Company (2021–2026)
2.3 Key Companies’ R&D and Operations Footprint and Headquarters
2.4 Key Companies Blood-based Biomarker Product Offerings
2.5 Key Companies General Availability (GA) Timeline for Blood-based Biomarker
2.6 Blood-based Biomarker Market Competitive Analysis
2.6.1 Blood-based Biomarker Market Concentration Rate (2021–2026)
2.6.2 Top 5 and Top 10 Global Companies by Blood-based Biomarker Revenue in 2025
2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood-based Biomarker revenue, 2025
2.7 Mergers & Acquisitions and Expansion
3 Segmentation Blood-based Biomarker Market Classification
3.1 Introduction by Type
3.1.1 Next Generation Sequencing
3.1.2 Mass Spectrometry
3.1.3 Liquid Biopsy Technologies
3.1.4 Global Blood-based Biomarker Sales Value by Type
3.1.4.1 Global Blood-based Biomarker Sales Value by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Blood-based Biomarker Sales Value, by Type (2021–2032)
3.1.4.3 Global Blood-based Biomarker Sales Value, by Type (%), 2021–2032
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Diagnostic Centers
4.1.3 Research Labs
4.2 Global Blood-based Biomarker Sales Value by Application
4.2.1 Global Blood-based Biomarker Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Blood-based Biomarker Sales Value by Application (2021–2032)
4.2.3 Global Blood-based Biomarker Sales Value by Application (%), 2021–2032
5 Segmentation by Region
5.1 Global Blood-based Biomarker Sales Value by Region
5.1.1 Global Blood-based Biomarker Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Blood-based Biomarker Sales Value by Region (2021–2026)
5.1.3 Global Blood-based Biomarker Sales Value by Region (2027–2032)
5.1.4 Global Blood-based Biomarker Sales Value by Region (%), 2021–2032
5.2 North America
5.2.1 North America Blood-based Biomarker Sales Value, 2021–2032
5.2.2 North America Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
5.3 Europe
5.3.1 Europe Blood-based Biomarker Sales Value, 2021–2032
5.3.2 Europe Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
5.4 Asia Pacific
5.4.1 Asia Pacific Blood-based Biomarker Sales Value, 2021–2032
5.4.2 Asia Pacific Blood-based Biomarker Sales Value by Subregion (%), 2025 vs 2032
5.5 South America
5.5.1 South America Blood-based Biomarker Sales Value, 2021–2032
5.5.2 South America Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
5.6 Middle East & Africa
5.6.1 Middle East & Africa Blood-based Biomarker Sales Value, 2021–2032
5.6.2 Middle East & Africa Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blood-based Biomarker Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Blood-based Biomarker Sales Value, 2021–2032
6.3 United States
6.3.1 United States Blood-based Biomarker Sales Value, 2021–2032
6.3.2 United States Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Blood-based Biomarker Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Blood-based Biomarker Sales Value, 2021–2032
6.4.2 Europe Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Blood-based Biomarker Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Blood-based Biomarker Sales Value, 2021–2032
6.5.2 China Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
6.5.3 China Blood-based Biomarker Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Blood-based Biomarker Sales Value, 2021–2032
6.6.2 Japan Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Blood-based Biomarker Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Blood-based Biomarker Sales Value, 2021–2032
6.7.2 South Korea Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Blood-based Biomarker Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Blood-based Biomarker Sales Value, 2021–2032
6.8.2 Southeast Asia Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Blood-based Biomarker Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Blood-based Biomarker Sales Value, 2021–2032
6.9.2 India Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
6.9.3 India Blood-based Biomarker Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Roche Diagnostics
7.1.1 Roche Diagnostics Profile
7.1.2 Roche Diagnostics Main Business
7.1.3 Roche Diagnostics Blood-based Biomarker Products, Services, and Solutions
7.1.4 Roche Diagnostics Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.1.5 Roche Diagnostics Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Blood-based Biomarker Products, Services, and Solutions
7.2.4 Thermo Fisher Scientific Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Bio-Rad Laboratories
7.3.1 Bio-Rad Laboratories Profile
7.3.2 Bio-Rad Laboratories Main Business
7.3.3 Bio-Rad Laboratories Blood-based Biomarker Products, Services, and Solutions
7.3.4 Bio-Rad Laboratories Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.3.5 Bio-Rad Laboratories Recent Developments
7.4 Qiagen
7.4.1 Qiagen Profile
7.4.2 Qiagen Main Business
7.4.3 Qiagen Blood-based Biomarker Products, Services, and Solutions
7.4.4 Qiagen Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.4.5 Qiagen Recent Developments
7.5 Abbott
7.5.1 Abbott Profile
7.5.2 Abbott Main Business
7.5.3 Abbott Blood-based Biomarker Products, Services, and Solutions
7.5.4 Abbott Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.5.5 Abbott Recent Developments
7.6 Siemens Healthineers
7.6.1 Siemens Healthineers Profile
7.6.2 Siemens Healthineers Main Business
7.6.3 Siemens Healthineers Blood-based Biomarker Products, Services, and Solutions
7.6.4 Siemens Healthineers Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.6.5 Siemens Healthineers Recent Developments
7.7 Danaher
7.7.1 Danaher Profile
7.7.2 Danaher Main Business
7.7.3 Danaher Blood-based Biomarker Products, Services, and Solutions
7.7.4 Danaher Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.7.5 Danaher Recent Developments
7.8 Quidel Corporation
7.8.1 Quidel Corporation Profile
7.8.2 Quidel Corporation Main Business
7.8.3 Quidel Corporation Blood-based Biomarker Products, Services, and Solutions
7.8.4 Quidel Corporation Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.8.5 Quidel Corporation Recent Developments
7.9 Grifols
7.9.1 Grifols Profile
7.9.2 Grifols Main Business
7.9.3 Grifols Blood-based Biomarker Products, Services, and Solutions
7.9.4 Grifols Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.9.5 Grifols Recent Developments
7.10 Biocartis
7.10.1 Biocartis Profile
7.10.2 Biocartis Main Business
7.10.3 Biocartis Blood-based Biomarker Products, Services, and Solutions
7.10.4 Biocartis Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.10.5 Biocartis Recent Developments
7.11 Vernalis
7.11.1 Vernalis Profile
7.11.2 Vernalis Main Business
7.11.3 Vernalis Blood-based Biomarker Products, Services, and Solutions
7.11.4 Vernalis Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.11.5 Vernalis Recent Developments
7.12 Labcorp Drug Development
7.12.1 Labcorp Drug Development Profile
7.12.2 Labcorp Drug Development Main Business
7.12.3 Labcorp Drug Development Blood-based Biomarker Products, Services, and Solutions
7.12.4 Labcorp Drug Development Blood-based Biomarker Revenue (US$ Million), 2021–2026
7.12.5 Labcorp Drug Development Recent Developments
8 Industry Chain Analysis
8.1 Blood-based Biomarker Value Chain
8.2 Blood-based Biomarker Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Cost Structure
8.3 Midstream Analysis
8.4 Downstream (Customer) Analysis
8.5 Sales Model and Sales Channelss
8.5.1 Blood-based Biomarker Sales Model
8.5.2 Sales Channels
8.5.3 Blood-based Biomarker Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Blood-based Biomarker Market Trends
Table 2. Blood-based Biomarker Market Drivers & Opportunities
Table 3. Blood-based Biomarker Market Challenges
Table 4. Blood-based Biomarker Market Restraints
Table 5. Global Blood-based Biomarker Revenue by Company (US$ Million), 2021–2026
Table 6. Global Blood-based Biomarker Revenue Market Share by Company (2021–2026)
Table 7. Key Companies’ R&D and Operations Footprint and Headquarters
Table 8. Key Companies Blood-based Biomarker Product Type
Table 9. Key Companies General Availability (GA) Timeline for Blood-based Biomarker
Table 10. Global Blood-based Biomarker Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Blood-based Biomarker revenue, 2025
Table 12. Mergers & Acquisitions and Expansion Plans
Table 13. Global Blood-based Biomarker Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 14. Global Blood-based Biomarker Sales Value by Type (US$ Million), 2021–2026
Table 15. Global Blood-based Biomarker Sales Value by Type (US$ Million), 2027–2032
Table 16. Global Blood-based Biomarker Sales Market Share in Value by Type (2021–2026)
Table 17. Global Blood-based Biomarker Sales Market Share in Value by Type (2027–2032)
Table 18. Global Blood-based Biomarker Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 19. Global Blood-based Biomarker Sales Value by Application (US$ Million), 2021–2026
Table 20. Global Blood-based Biomarker Sales Value by Application (US$ Million), 2027–2032
Table 21. Global Blood-based Biomarker Sales Market Share in Value by Application (2021–2026)
Table 22. Global Blood-based Biomarker Sales Market Share in Value by Application (2027–2032)
Table 23. Global Blood-based Biomarker Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 24. Global Blood-based Biomarker Sales Value by Region (US$ Million), 2021–2026
Table 25. Global Blood-based Biomarker Sales Value by Region (US$ Million), 2027–2032
Table 26. Global Blood-based Biomarker Sales Value by Region (%), 2021–2026
Table 27. Global Blood-based Biomarker Sales Value by Region (%), 2027–2032
Table 28. Key Countries/Regions Blood-based Biomarker Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 29. Key Countries/Regions Blood-based Biomarker Sales Value, (US$ Million), 2021–2026
Table 30. Key Countries/Regions Blood-based Biomarker Sales Value, (US$ Million), 2027–2032
Table 31. Roche Diagnostics Basic Information List
Table 32. Roche Diagnostics Description and Business Overview
Table 33. Roche Diagnostics Blood-based Biomarker Products, Services, and Solutions
Table 34. Revenue (US$ Million) in Blood-based Biomarker Business of Roche Diagnostics (2021–2026)
Table 35. Roche Diagnostics Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific Blood-based Biomarker Products, Services, and Solutions
Table 39. Revenue (US$ Million) in Blood-based Biomarker Business of Thermo Fisher Scientific (2021–2026)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. Bio-Rad Laboratories Basic Information List
Table 42. Bio-Rad Laboratories Description and Business Overview
Table 43. Bio-Rad Laboratories Blood-based Biomarker Products, Services, and Solutions
Table 44. Revenue (US$ Million) in Blood-based Biomarker Business of Bio-Rad Laboratories (2021–2026)
Table 45. Bio-Rad Laboratories Recent Developments
Table 46. Qiagen Basic Information List
Table 47. Qiagen Description and Business Overview
Table 48. Qiagen Blood-based Biomarker Products, Services, and Solutions
Table 49. Revenue (US$ Million) in Blood-based Biomarker Business of Qiagen (2021–2026)
Table 50. Qiagen Recent Developments
Table 51. Abbott Basic Information List
Table 52. Abbott Description and Business Overview
Table 53. Abbott Blood-based Biomarker Products, Services, and Solutions
Table 54. Revenue (US$ Million) in Blood-based Biomarker Business of Abbott (2021–2026)
Table 55. Abbott Recent Developments
Table 56. Siemens Healthineers Basic Information List
Table 57. Siemens Healthineers Description and Business Overview
Table 58. Siemens Healthineers Blood-based Biomarker Products, Services, and Solutions
Table 59. Revenue (US$ Million) in Blood-based Biomarker Business of Siemens Healthineers (2021–2026)
Table 60. Siemens Healthineers Recent Developments
Table 61. Danaher Basic Information List
Table 62. Danaher Description and Business Overview
Table 63. Danaher Blood-based Biomarker Products, Services, and Solutions
Table 64. Revenue (US$ Million) in Blood-based Biomarker Business of Danaher (2021–2026)
Table 65. Danaher Recent Developments
Table 66. Quidel Corporation Basic Information List
Table 67. Quidel Corporation Description and Business Overview
Table 68. Quidel Corporation Blood-based Biomarker Products, Services, and Solutions
Table 69. Revenue (US$ Million) in Blood-based Biomarker Business of Quidel Corporation (2021–2026)
Table 70. Quidel Corporation Recent Developments
Table 71. Grifols Basic Information List
Table 72. Grifols Description and Business Overview
Table 73. Grifols Blood-based Biomarker Products, Services, and Solutions
Table 74. Revenue (US$ Million) in Blood-based Biomarker Business of Grifols (2021–2026)
Table 75. Grifols Recent Developments
Table 76. Biocartis Basic Information List
Table 77. Biocartis Description and Business Overview
Table 78. Biocartis Blood-based Biomarker Products, Services, and Solutions
Table 79. Revenue (US$ Million) in Blood-based Biomarker Business of Biocartis (2021–2026)
Table 80. Biocartis Recent Developments
Table 81. Vernalis Basic Information List
Table 82. Vernalis Description and Business Overview
Table 83. Vernalis Blood-based Biomarker Products, Services, and Solutions
Table 84. Revenue (US$ Million) in Blood-based Biomarker Business of Vernalis (2021–2026)
Table 85. Vernalis Recent Developments
Table 86. Labcorp Drug Development Basic Information List
Table 87. Labcorp Drug Development Description and Business Overview
Table 88. Labcorp Drug Development Blood-based Biomarker Products, Services, and Solutions
Table 89. Revenue (US$ Million) in Blood-based Biomarker Business of Labcorp Drug Development (2021–2026)
Table 90. Labcorp Drug Development Recent Developments
Table 91. Revenue (US$ Million) in Blood-based Biomarker Business of Company 40 (2021–2026)
Table 92. Company 40 Recent Developments
Table 93. Key Raw Materials Lists
Table 94. Key Suppliers of Raw Materials Lists
Table 95. Blood-based Biomarker Downstream Customers
Table 96. Blood-based Biomarker Distributors List
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood-based Biomarker Product Picture
Figure 2. Global Blood-based Biomarker Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 4. Blood-based Biomarker Report Years Considered
Figure 5. Global Blood-based Biomarker Players Revenue Ranking (US$ Million), 2025
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Blood-based Biomarker Revenue in 2025
Figure 7. Blood-based Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 8. Next Generation Sequencing Picture
Figure 9. Mass Spectrometry Picture
Figure 10. Liquid Biopsy Technologies Picture
Figure 11. Global Blood-based Biomarker Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Blood-based Biomarker Sales Value Market Share by Type, 2025 & 2032
Figure 13. Product Picture of Hospital
Figure 14. Product Picture of Diagnostic Centers
Figure 15. Product Picture of Research Labs
Figure 16. Global Blood-based Biomarker Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Blood-based Biomarker Sales Value Market Share by Application, 2025 & 2032
Figure 18. North America Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 19. North America Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
Figure 20. Europe Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 21. Europe Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
Figure 22. Asia Pacific Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 23. Asia Pacific Blood-based Biomarker Sales Value by Subregion (%), 2025 vs 2032
Figure 24. South America Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 25. South America Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
Figure 26. Middle East & Africa Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 27. Middle East & Africa Blood-based Biomarker Sales Value by Country (%), 2025 vs 2032
Figure 28. Key Countries/Regions Blood-based Biomarker Sales Value (%), 2021–2032
Figure 29. United States Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 30. United States Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
Figure 31. United States Blood-based Biomarker Sales Value by Application (%), 2025 vs 2032
Figure 32. Europe Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 33. Europe Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
Figure 34. Europe Blood-based Biomarker Sales Value by Application (%), 2025 vs 2032
Figure 35. China Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 36. China Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
Figure 37. China Blood-based Biomarker Sales Value by Application (%), 2025 vs 2032
Figure 38. Japan Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 39. Japan Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
Figure 40. Japan Blood-based Biomarker Sales Value by Application (%), 2025 vs 2032
Figure 41. South Korea Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 42. South Korea Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
Figure 43. South Korea Blood-based Biomarker Sales Value by Application (%), 2025 vs 2032
Figure 44. Southeast Asia Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 45. Southeast Asia Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
Figure 46. Southeast Asia Blood-based Biomarker Sales Value by Application (%), 2025 vs 2032
Figure 47. India Blood-based Biomarker Sales Value (US$ Million), 2021–2032
Figure 48. India Blood-based Biomarker Sales Value by Type (%), 2025 vs 2032
Figure 49. India Blood-based Biomarker Sales Value by Application (%), 2025 vs 2032
Figure 50. Blood-based Biomarker Value Chain
Figure 51. Blood-based Biomarker Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Blood-based Biomarker market size from 2026 to 2032?
The annual compound growth rate of the global Blood-based Biomarker market is 10.4% 2026 to 2032.
Which region is expected to have the highest market share?
What was the global market size of Blood-based Biomarker in 2026?
Which companies rank high in the global Blood-based Biomarker market?
What was the global market size of Blood-based Biomarker in 2032?
Related Reports
Global Blood-based Biomarker Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3977 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-11
Pages: 140
USD 4900.00
(Single User License)
Global Blood-based Biomarker Market Research Report 2026
The global Blood-based Biomarker market was valued at US$ 2015 million in 2025 and is anticipated to reach US$ 3977 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 116
USD 2900.00
(Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Blood-based Biomarker market size was US$ 2015 million in 2025 and is forecast to reach a readjusted size of US$ 3977 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 97
USD 4250.00
(Single User License)
Global Blood-based Biomarker Market Insights, Forecast to 2031
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3638 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
Published Date: 2025-03-28
Pages: 143
USD 4900.00
(Single User License)
Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood-based Biomarker market size was US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 92
USD 4250.00
(Single User License)
Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Blood-based Biomarker was estimated to be worth US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 101
USD 3950.00
(Single User License)
Global Blood-based Biomarker Market Research Report 2025
The global market for Blood-based Biomarker was valued at US$ 1867 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published Date: 2025-03-28
Pages: 85
USD 2900.00
(Single User License)
Global Blood-based Biomarker Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3977 million by 2032, at a CAGR of 10.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-11
Pages: 140
USD 4900.00 (Single User License)Global Blood-based Biomarker Market Research Report 2026
The global Blood-based Biomarker market was valued at US$ 2015 million in 2025 and is anticipated to reach US$ 3977 million by 2032, at a CAGR of 10.4% from 2026 to 2032.
Published: 2026-03-11
Pages: 116
USD 2900.00 (Single User License)Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Blood-based Biomarker market size was US$ 2015 million in 2025 and is forecast to reach a readjusted size of US$ 3977 million by 2032 with a CAGR of 10.4% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 97
USD 4250.00 (Single User License)Global Blood-based Biomarker Market Insights, Forecast to 2031
The global Blood-based Biomarker market is projected to grow from US$ 2015 million in 2025 to US$ 3638 million by 2031, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.
Published: 2025-03-28
Pages: 143
USD 4900.00 (Single User License)Global Blood-based Biomarker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Blood-based Biomarker market size was US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 92
USD 4250.00 (Single User License)Blood-based Biomarker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Blood-based Biomarker was estimated to be worth US$ 1867 million in 2024 and is forecast to a readjusted size of US$ 3638 million by 2031 with a CAGR of 10.4% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 101
USD 3950.00 (Single User License)Global Blood-based Biomarker Market Research Report 2025
The global market for Blood-based Biomarker was valued at US$ 1867 million in the year 2024 and is projected to reach a revised size of US$ 3638 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Published: 2025-03-28
Pages: 85
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now